Cargando…

Skin autofluorescence, a non-invasive biomarker for advanced glycation end products, is associated with the metabolic syndrome and its individual components

BACKGROUND: The metabolic syndrome (MetS) comprises several cardiometabolic risk factors associated with increased risk for both type 2 diabetes and cardiovascular disease. Skin autofluorescence (SAF), a non-invasive biomarker of advanced glycation end products accumulation, is associated with cardi...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Waateringe, Robert P., Slagter, Sandra N., van Beek, Andre P., van der Klauw, Melanie M., van Vliet-Ostaptchouk, Jana V., Graaff, Reindert, Paterson, Andrew D., Lutgers, Helen L., Wolffenbuttel, Bruce H. R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450154/ https://www.ncbi.nlm.nih.gov/pubmed/28572855 http://dx.doi.org/10.1186/s13098-017-0241-1

Ejemplares similares

Lifestyle and clinical determinants of skin autofluorescence in a population‐based cohort study
por: van Waateringe, Robert P., et al.
Publicado: (2016)

The association between various smoking behaviors, cotinine biomarkers and skin autofluorescence, a marker for advanced glycation end product accumulation
por: van Waateringe, Robert P., et al.
Publicado: (2017)

Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease and mortality in the general population
por: van Waateringe, Robert P., et al.
Publicado: (2018)

Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes
por: Boersma, Henderikus E., et al.
Publicado: (2021)

Sex, BMI and age differences in metabolic syndrome: the Dutch Lifelines Cohort Study
por: Slagter, Sandra N, et al.
Publicado: (2017)

The Association Between Anemia and Skin Autofluorescence, a Marker for Advanced Glycation End Product Accumulation
por: Wouters, Hanneke J.C.M., et al.
Publicado: (2020)

Health-Related Quality of Life in Relation to Obesity Grade, Type 2 Diabetes, Metabolic Syndrome and Inflammation
por: Slagter, Sandra N., et al.
Publicado: (2015)

Thyroid function and metabolic syndrome in the population-based LifeLines cohort study
por: Wolffenbuttel, Bruce H. R., et al.
Publicado: (2017)

Associations between smoking, components of metabolic syndrome and lipoprotein particle size
por: Slagter, Sandra N, et al.
Publicado: (2013)

Genome-wide association study identifies novel loci associated with skin autofluorescence in individuals without diabetes
por: Vollenbrock, Charlotte E., et al.
Publicado: (2022)

A non-invasive risk score including skin autofluorescence predicts diabetes risk in the general population
por: Boersma, Henderikus E., et al.
Publicado: (2022)

Combined Effects of Smoking and Alcohol on Metabolic Syndrome: The LifeLines Cohort Study
por: Slagter, Sandra N., et al.
Publicado: (2014)

New Locus for Skin Intrinsic Fluorescence in Type 1 Diabetes Also Associated With Blood and Skin Glycated Proteins
por: Roshandel, Delnaz, et al.
Publicado: (2016)

Advanced glycation end products measured by skin autofluorescence in a population with central obesity
por: den Engelsen, Corine, et al.
Publicado: (2012)

GWAS identifies an NAT2 acetylator status tag single nucleotide polymorphism to be a major locus for skin fluorescence
por: Eny, Karen M., et al.
Publicado: (2014)

DNA methylation markers associated with type 2 diabetes, fasting glucose and HbA(1c) levels: a systematic review and replication in a case–control sample of the Lifelines study
por: Walaszczyk, Eliza, et al.
Publicado: (2017)

Development and Interlaboratory Validation of Two Fast UPLC–MS-MS Methods Determining Urinary Bisphenols, Parabens and Phthalates
por: van der Meer, Thomas P, et al.
Publicado: (2019)

Exposure to Endocrine Disrupting Chemicals in the Dutch general population is associated with adiposity-related traits
por: van der Meer, Thomas P., et al.
Publicado: (2020)

Dietary patterns and physical activity in the metabolically (un)healthy obese: the Dutch Lifelines cohort study
por: Slagter, Sandra N., et al.
Publicado: (2018)

Skin Autofluorescence, a Noninvasive Biomarker for Advanced Glycation End-products, Is Associated With Sarcopenia
por: Waqas, Komal, et al.
Publicado: (2021)

Skin Autofluorescence Relates to Soluble Receptor for Advanced Glycation End-Products and Albuminuria in Diabetes Mellitus
por: Škrha, J., et al.
Publicado: (2013)

Advanced glycation end products measured by skin autofluorescence and subclinical cardiovascular disease: the Rotterdam Study
por: Chen, Jinluan, et al.
Publicado: (2023)

Epidemiology of thyroid disorders in the Lifelines Cohort Study (the Netherlands)
por: Wouters, Hanneke J. C. M., et al.
Publicado: (2020)

Serum 25-hydroxyvitamin D(3) is associated with advanced glycation end products (AGEs) measured as skin autofluorescence: The Rotterdam Study
por: Chen, Jinluan, et al.
Publicado: (2018)

Skin Autofluorescence, as Marker of Accumulation of Advanced Glycation Endproducts and of Cumulative Metabolic Stress, Is Not Increased in Patients with Systemic Sclerosis
por: Hettema, M. E., et al.
Publicado: (2011)

Skin Autofluorescence, a Noninvasive Biomarker for Advanced Glycation End‐Products, Is Associated With Prevalent Vertebral and Major Osteoporotic Fractures: The Rotterdam Study
por: Waqas, Komal, et al.
Publicado: (2020)

Advanced glycation end products (AGEs) estimated by skin autofluorescence are related with cardiovascular risk in renal transplant
por: Calviño, Jesus, et al.
Publicado: (2018)

Evaluation of Relevance between Advanced Glycation End Products and Diabetic Retinopathy Stages Using Skin Autofluorescence
por: Takayanagi, Yuji, et al.
Publicado: (2020)

Skin Autofluorescence, a Noninvasive Biomarker of Advanced Glycation End-products, Is Associated With Frailty: The Rotterdam Study
por: Waqas, Komal, et al.
Publicado: (2022)

The Role of Advanced Glycation End-Product Levels Measured by Skin Autofluorescence in the Development of Mitral Annular Calcification
por: Boyraz, Bedrettin, et al.
Publicado: (2023)

Autofluorescence as a noninvasive biomarker of senescence and advanced glycation end products in Caenorhabditis elegans
por: Komura, Tomomi, et al.
Publicado: (2021)

Association of advanced glycation end products, evaluated by skin autofluorescence, with lifestyle habits in a general Japanese population
por: Isami, Fumiyuki, et al.
Publicado: (2018)

Factors Associated With Change in Skin Autofluorescence, a Measure of Advanced Glycation End Products, in Persons Receiving Dialysis
por: Viramontes Hörner, Daniela, et al.
Publicado: (2020)

Is skin autofluorescence (SAF) representative of dermal advanced glycation endproducts (AGEs) in dark skin? A pilot study
por: Atzeni, Isabella M., et al.
Publicado: (2020)

Relationship Between Clinical Symptoms and Skin Autofluorescence in Hemodialysis Patients as a Measure of Advanced Glycation End-Product Accumulation
por: Suzuki, Masahiro, et al.
Publicado: (2022)

Higher hydrocortisone dose increases bilirubin in hypopituitary patients‐ results from an RCT
por: Werumeus Buning, Jorien, et al.
Publicado: (2016)

Skin Autofluorescence: A Pronounced Marker of Mortality in Hemodialysis Patients
por: Gerrits, Esther G., et al.
Publicado: (2012)

Distribution of Non-Persistent Endocrine Disruptors in Two Different Regions of the Human Brain
por: van der Meer, Thomas P., et al.
Publicado: (2017)

Association of Advanced Glycation End Products with coronary Artery Calcification in Japanese Subjects with Type 2 Diabetes as Assessed by Skin Autofluorescence
por: Hangai, Mari, et al.
Publicado: (2016)

Accumulation of advanced glycation end products evaluated by skin autofluorescence and incident frailty in older adults from the Bordeaux Three-City cohort
por: Pilleron, Sophie, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4kqkgpn0vn0m434v7ts4l6dkuc